Comparative analysis of DC fused with allogeneic hepatocellular carcinoma cell line HepG2 and autologous tumor cells as potential cancer vaccines against hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2009-05-27 / Cell. Immunol. 2009;259(1):13-20Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer
/in Dendritic Cells, Esophageal Carcinoma, International Publications /von 2009-05-14 / Cancer Sci. 2009 Aug;100(8):1502-9On immunotherapies and cancer vaccination protocols: a mathematical modelling approach
/in Dendritic Cells, International Publications /von 2009-05-14 / J. Theor. Biol. 2009 Aug;259(4):820-7Increases in serum TARC/CCL17 levels are associated with progression-free survival in advanced melanoma patients in response to dendritic cell-based immunotherapy
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2009-05-07 / J. Clin. Immunol. 2009 Sep;29(5):657-64Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2009-05-05 / Clin. Cancer Res. 2009 May;15(10):3366-75Effect of hyperthermia combined with gemcitabine on apoptotic cell death in cultured human pancreatic cancer cell lines
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2009-05-01 / Int J Hyperthermia 2009 May;25(3):210-9Synergistic effect of dendritic cell vaccination and anti-CD20 antibody treatment in the therapy of murine lymphoma
/in Dendritic Cells, International Publications, Malignant Lymphoma /von 2009-05-01 / J. Immunother. 2009 May;32(4):333-40Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization
/in Dendritic Cells, International Publications, Prostate Cancer /von 2009-05-01 / Prostate 2009 May;69(6):571-84Tumor vaccines for breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2009-05-01 / Cancer Invest. 2009 May;27(4):361-8
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution